Europe

3i’s Severin Matten: AI turning outside-in due diligence into a ‘prerequisite’

Pharma and life science dealmaking is set for an uptick in 2024, said 3i’s Matten.

Investcorp picks up HR software biz Veda

General Atlantic talks 2024 dealmaking; PAI to part with ELITech.

PAI looking at 3.7x return with ELITech sale

Bruker Corporation has signed an agreement with the private equity firm that includes a put option to buy ELITech.

Investcorp enters €3bn DACH HR software market with Veda

Veda’s revenues were around €20 million in 2023.

General Atlantic’s Gabriel Caillaux expects dealmaking to shift back to basics in 2024

'One of the silver linings of the market correction is that the days of companies selling products at negative gross margins are gone.'

Consilium exits GMM Group to Biesse

GMM is a traditional and computer numerical control milling machines producer.

Oakley-backed 7NXT picks up 7Mind

7NXT owns and operates fitness platform Gymondo.

PE Hub Europe’s top 10 of 2023

PSG and Riverside’s 2024 tips; Mutares reveals Prénatal plans.

Ardian, Tikehau Capital, EMZ back Vulcain Engineering

Vulcain is an engineering group that specialises in energy transition and life sciences.